Tomer Cooks

Medicine & Life Sciences

1. Alpha Particles 100%
2. Anti-Inflammatory Agents 10%
3. Bevacizumab 11%
4. Bifidobacterium longum 15%
5. Brachytherapy 16%
6. Breast Neoplasms 9%
7. Carcinogenesis 8%
8. Colon 11%
9. Colonic Neoplasms 15%
10. Colorectal Neoplasms 30%
11. Comamonadaceae 31%
12. Combination Drug Therapy 11%
13. Cytoplasm 8%
14. Drug Therapy 18%
15. Exosomes 29%
16. Extracellular Vesicles 73%
17. Galectin 3 13%
18. Genome 9%
19. Glioblastoma 11%
20. Growth 15%
21. Head and Neck Neoplasms 20%
22. Heterografts 12%
23. Histones 9%
24. Immunotherapy 19%
25. In Vitro Techniques 7%
26. Inflammation 32%
27. Lung 17%
28. Lung Neoplasms 32%
29. Macrophages 32%
30. Microbiota 41%
31. Mutant Proteins 13%
32. Mutation 18%
33. Neoplasms 92%
34. Neoplastic Stem Cells 11%
35. NF-kappa B 13%
36. Nude Mice 12%
37. p53 Genes 27%
38. Proteins 10%
39. Proteomics 9%
40. Publications 8%
41. Radiotherapy 25%
42. Seeds 11%
43. Software 7%
44. Squamous Cell Carcinoma 30%
45. Temozolomide 12%
46. Therapeutics 15%
47. thorium X 36%
48. trametinib 8%
49. Tumor Microenvironment 56%
50. Ubiquitination 11%